Medical Devices Startups
5,183 companies tagged Medical Devices, with their investors and founders.
Smart Reporting, operating as Jacobian, builds AI-powered structured reporting and workflow software for radiologists and diagnostic imaging teams, including its Fluency for Imaging speech recognition product. The platform uses disease-specific models, guideline-based data, and integrations with RIS, PACS, and EMR systems (HL7/FHIR) to support standardized medical reporting for healthcare providers.
3 investors
Smith+Nephew is a medical technology company that develops products for the repair, regeneration, and replacement of soft and hard tissue, including sports medicine solutions for treating sporting injuries. Its technology is used by surgeons to help patients recover and regain mobility.
3 investors
Solid IO develops a tumor-on-chip platform using organ-on-chip technology and AI to model patient-specific tumor microenvironments for oncology and immunotherapy research. The platform enables pharmaceutical companies, biotech firms, and cancer clinics to predict treatment responses, accelerate drug development, and support precision medicine in cancer care.
3 investors
Solis Mammography operates specialized breast imaging centers offering screening and diagnostic mammograms using 3D mammography and SmartCurve compression technology, along with AI-assisted early cancer detection. It serves women seeking breast health screenings, with locations across U.S. markets including Texas, Ohio, Pennsylvania, and Colorado.
3 investors
Sonogen Medical develops a portable, connected home device for bone growth stimulation to help treat bone fractures, offering shorter daily usage sessions and healing feedback. It targets patients recovering from fractures, positioning its product as an alternative to older bone growth stimulation technology.
3 investors
Sonovascular is developing an interventional treatment for venous thromboembolism (VTE) that uses microbubble-mediated cavitation, delivered as a cath lab-based procedure without requiring ICU treatment. The company operates in the cardiovascular medical device space.
3 investors
Sooma Medical develops and manufactures transcranial direct current stimulation (tDCS) devices for treating major depressive disorder, fibromyalgia, and chronic neuropathic pain without medication. The company serves clinics, hospitals, and universities globally through neuromodulation technology approved for clinical use and research.
3 investors
SpectraWAVE develops optical and computational imaging technologies to diagnose and guide treatment decisions for patients with coronary artery disease and cardiovascular disease. The company operates vertically integrated design, manufacturing, and commercialization operations for its medical devices.
3 investors
Spiderwort Biotechnologies is a biotechnology company developing natural, science-based solutions with potential applications across multiple industries.
3 investors
SpyGlass Pharma develops a sustained drug delivery platform for treating chronic ophthalmic diseases such as glaucoma, integrating drugs, procedures, and devices for long-term disease control and vision preservation. It serves the ophthalmic care market, spanning discovery through late-stage clinical development and commercialization.
3 investors
Standard Cyborg provides cloud and edge infrastructure that enables developers and non-technical users to construct, test, and optimize computer vision applications without specialized expertise.
3 investors
QIAGEN provides sample preparation and molecular testing technologies, including automated DNA/RNA extraction, digital PCR, and syndromic testing systems. Its products serve laboratories in clinical diagnostics, applied testing, and life science research.
3 investors
Stately Bio develops stem cell-derived regenerative and cell therapies using a machine learning platform that measures cell identity, behavior, and maturation directly from live-cell, label-free imaging. It partners with institutions and companies in the cell therapy field to support therapy discovery and manufacturing.
3 investors
Strand is a clinical-stage biotechnology company developing programmable mRNA therapeutics for cancers and autoimmune diseases. The company has created an mRNA platform with cell-selective targeting capabilities to deliver therapeutic payloads within the body.
3 investors
Noze develops a breath-analysis platform that uses nano-sensor "smell on silicon" chips and AI neural models to detect trace molecular patterns in exhaled breath and translate them into diagnostic signals. The device, aimed at clinical diagnostics and point-of-care use, is still under development and not yet cleared for commercial sale.
3 investors
Surf Therapeutics develops a non-invasive broad-beam ultrasound platform that stimulates nerves to activate the body's cholinergic anti-inflammatory pathway, aiming to restore immune balance and treat inflammatory and autoimmune disorders without drugs. The technology is designed for at-home use to manage chronic inflammation.
3 investors
Surgify Halo is a medical technology company that develops innovative bone cutting technology designed to improve safety, precision, and efficacy in surgical procedures.
3 investors
SUSMED (γ΅γΉγ‘γζ ͺεΌδΌη€Ύ) develops therapeutic apps (digital therapeutics) and a blockchain-based clinical trial system, and provides medical data analysis using statistics and machine learning. The Japanese company serves pharmaceutical companies and medical research institutions, including a marketed prescription app for insomnia.
3 investors
Syantra develops the patent-pending Onco-ID platform for early cancer detection, using a biomarker and drug target discovery technology to support oncologists and pharmaceutical scientists in creating personalized, precision cancer treatments. Founded from research at the University of Calgary, it serves the oncology diagnostics and precision medicine market.
3 investors
Sycai Medical is a Barcelona-based medtech company developing AI algorithms that help radiologists detect and assess abdominal lesions, supporting earlier diagnosis of pancreatic and other abdominal cancers. It serves radiologists and healthcare professionals in medical imaging and cancer care.
3 investors
A drug discovery company founded by an experienced medicinal chemistry team with expertise in successful pharmaceutical development and clinical advancement.
3 investors
Tenpoint Therapeutics develops treatments for age-related ophthalmic conditions, with an initial focus on presbyopia care for the aging eye. The company works with eye care professionals to advance therapies in the ophthalmology market.
3 investors
TenSixty uses machine learning and cell biology expertise to identify novel antibody targets on cancer cells for the development of new cancer therapeutics. The company combines AI with high-throughput technologies to discover improved drug candidates for oncology.
3 investors
Terrestrial is developing the Tacterra microarray patch (MAP) platform, which uses dissolvable tips made from biomaterials to deliver therapies such as GLP-1 through the skin without injections. The platform is designed for patient self-administration at home or while traveling, removing the need for sharps and refrigeration.
3 investors